We are live on ! Find out more
FCE

Fiera Capital (Europe) Portfolio holdings

AUM $213M
1-Year Est. Return 42.35%
This Fund
S&P 500
This Quarter Est. Return
-0.46%
1 Year Est. Return
+42.35%
3 Year Est. Return
+41.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$172M
AUM Growth
+$2.72M
Cap. Flow
+$9.96M
Cap. Flow %
5.77%
Top 10 Hldgs %
73.91%
Holding
46
New
5
Increased
12
Reduced
13
Closed
6

Top Buys

Rank Stock Value
1
PBR.A icon
Petrobras Class A
PBR.A
+$5.59M
2
TGS icon
Transportadora de Gas del Sur
TGS
+$4.61M
3
MELI icon
Mercado Libre
MELI
+$3.12M
4
EDN
Edenor
EDN
+$3M
5
TEO icon
Telecom Argentina
TEO
+$2.83M

Top Sells

Rank Stock Value
1
VEON icon
VEON
VEON
+$3.95M
2
ABEV icon
Ambev
ABEV
+$2.22M
3
PAM icon
Pampa Energía
PAM
+$1.35M
4
TAL icon
TAL Education Group
TAL
+$796K
5
ABMD
Abiomed Inc
ABMD
+$572K

Sector Composition

Rank Sector Weight
1 Financials 31.86%
2 Communication Services 20.43%
3 Consumer Discretionary 14.08%
4 Consumer Staples 11.7%
5 Energy 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
26
Pfizer
PFE
$153B
$274K 0.16%
8,923
-3,960
-31% -$121K
PEN icon
27
Penumbra
PEN
$12.8B
$268K 0.16%
4,230
– –
BMY icon
28
Bristol-Myers Squibb
BMY
$132B
$253K 0.15%
4,347
– –
UGP icon
29
Ultrapar
UGP
$6.54B
$249K 0.14%
24,096
+296
+1% +$3.11K
AMGN icon
30
Amgen
AMGN
$222B
$238K 0.14%
1,633
– –
CELG
31
DELISTED
Celgene Corp
CELG
$234K 0.14%
2,026
– –
LLY icon
32
Eli Lilly
LLY
$1.06T
$230K 0.13%
+3,135
New +$233K
NBIX icon
33
Neurocrine Biosciences
NBIX
$16.6B
$215K 0.12%
5,584
– –
BRFS
34
DELISTED
BRF SA
BRFS
$174K 0.1%
11,839
-837
-7% -$13.2K
AKRX
35
DELISTED
Akorn Inc
AKRX
$169K 0.1%
7,763
– –
ARWR icon
36
Arrowhead Research
ARWR
$12.4B
$159K 0.09%
+102,815
New +$438K
VALE icon
37
Vale
VALE
$62.6B
$159K 0.09%
20,841
-2,951
-12% -$21.6K
LCI
38
DELISTED
Lannett Company, Inc.
LCI
$138K 0.08%
1,581
– –
AMRN
39
Amarin Corp
AMRN
$303M
$116K 0.07%
+1,894
New +$120K
VIV icon
40
Telefônica Brasil
VIV
$19.2B
$104K 0.06%
7,788
-1,938
-20% -$26K
ABT icon
41
Abbott
ABT
$187B
– –
-5,711
Closed -$242K
DXCM icon
42
DexCom
DXCM
$32B
– –
-24,692
Closed -$543K
EW icon
43
Edwards Lifesciences
EW
$51.7B
– –
-8,262
Closed -$333K
TMO icon
44
Thermo Fisher Scientific
TMO
$220B
– –
-2,020
Closed -$322K
WAT icon
45
Waters Corp
WAT
$39.9B
– –
-1,771
Closed -$282K
ABMD
46
DELISTED
Abiomed Inc
ABMD
– –
-4,437
Closed -$572K
1
2

Similar funds

LWM
LBA Wealth Management Jacksonville, Florida $190M AUM 12.13% 1-Year Est. Return
KKAMG
Kernodle & Katon Asset Management Group Searcy, Arkansas $167M AUM 10.03% 1-Year Est. Return
MTIP
Magee Thomson Investment Partners San Diego, California $259M AUM 34.48% 1-Year Est. Return
IMIM
Irving Magee Investment Management Conshohocken, Pennsylvania $260M AUM 32.44% 1-Year Est. Return
CFA
CT Financial Advisors Chadds Ford, Pennsylvania $162M AUM 9.58% 1-Year Est. Return
PEI
Permira Europe III St. Peter Port, Guernsey $157M AUM
DCM
Dialectic Capital Management Norwalk, Connecticut $155M AUM 59.34% 1-Year Est. Return
ACM
Astenbeck Capital Management Southport, Connecticut $130M AUM 8.61% 1-Year Est. Return

Fiera Capital (Europe)'s Q4 2016 Portfolio in Review

As of Q4 2016, Fiera Capital (Europe) held 46 positions worth $172M, up 1.6% from $170M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Fiera Capital (Europe) deployed $9.96M of net new capital in Q4 2016, opening 5 new positions and adding to 12 existing holdings. Its largest new stake was Transportadora de Gas del Sur: 622,543 shares worth $5.38M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, down from 33% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was VEON, an estimated $3.95M trimmed.

  • Fiera Capital (Europe)'s largest Q4 2016 buy was Transportadora de Gas del Sur: 622,543 shares worth $5.38M.
  • Fiera Capital (Europe) added most to Petrobras Class A in Q4 2016, an estimated $5.59M increase.
  • Fiera Capital (Europe)'s biggest Q4 2016 reduction was VEON, cutting an estimated $3.95M.
  • Fiera Capital (Europe) fully exited Abiomed Inc in Q4 2016, selling an estimated $572K.
  • Fiera Capital (Europe)'s ten largest holdings make up 74% of its $172M portfolio in Q4 2016.
  • Fiera Capital (Europe) opened 5 new positions and closed 6 in Q4 2016.
  • Fiera Capital (Europe)'s portfolio value rose 1.6% quarter-over-quarter to $172M.

Based on Fiera Capital (Europe)'s 13F filing for Q4 2016, filed 13 Feb 2017.